Synthetic oligodeoxynucleotides represent promising tools for gene inhibition in live systems. Triple helix-forming oligonucleotides, which bind to double-stranded DNA, are of special interest since they are targeted to the gene itself rather than to its mRNA product, as in the antisense strategy. Triple helix-forming oligonucleotides can be coupled to DNA-modifying agents and used to introduce modifications in the DNA target in a highly sequence-specific manner. We have recently designed psoralen-oligonucleotide conjugates, which, upon binding to double-stranded DNA sequences via triple helix formation, may be cross-linked in vitro to both strands of the DNA following UV irradiation. A psoralen-oligonucleotide conjugate was targeted to tht promoter of the a subunit of the interleukin 2 receptor (IL-2Ra) gene. The triple helix site overlaps the binding site for the transcription factor NF-KB, which activates transcription from the IL-2Ra promoter. After UV irradiation, the oligonucleotide conXjugate becomes crosslinked to the target site and inhibits transcription of reporter plasmids transfected in live cells. Inhibition is observed when UV-induced cross-linking occurs both in vitro (before transfection) and in vivo (after transfection). We directly demonstrate that this inhibitory effect is due to triple helix formation at the target site, since a mutant of the promoter, to which oligonucleotide binding was inhibited, was not affected by the psoralenoligonucleotide conjugate after UV irradiation. In addition, we demonstrate that site-specific cross-linking upstream of the promoter has no effect on transcription.
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Synthetic oligonucleotides represent promising tools for gene inhibition in live systems (reviewed in ref. 1) . Several strategies have been developed with distinct intracellular targets for the oligonucleotide. Antisense oligonucleotides are targeted to mRNAs and inhibit mRNA translation (1) . In an alternative approach, oligonucleotides are designed to prevent transcription enhancement by transcription factors. Double-stranded synthetic enhancers have been used to trap transcription factors with variable success (2, 3) . Triple helix-forming oligonucleotides bind to double-stranded DNA and are expected to inhibit transcription either through inhibition of transcription factor binding or by directly acting as transcriptional repressors (4) (5) (6) (7) (8) (9) (10) (11) . Binding of triple helixforming oligonucleotides to gene promoters is expected to be more selective than trapping of transcription factors by synthetic enhancers. Transcription factors are involved in regulation of several distinct genes, whereas the target of triple helix-forming oligonucleotides, which need only overlap the transcription factor binding site, may be chosen in such a way as to be specific for the gene of interest. Oligonucleotide-directed triple helices can be stabilized by chemical modifications of oligonucleotides, such as covalent attachment of an acridine molecule (11) .
In an alternative approach, triple helix-forming oligonucleotides may be used to introduce permanent damage into the target sequence. This type of strategy could represent a major improvement for gene inhibition. Introduction of permanent damage into the target gene may result in irreversible inactivation of the gene. We have recently described the design of psoralen-oligonucleotide conjugates, which can be used to cross-link the two strands of DNA in a highly sequence-specific manner (12, 13) . The advantage ofpsoralen conjugates over simple intercalator molecules such as acridine is that, upon binding to double-stranded DNA sequences via triple helix formation, they can induce irreversible reactions in the DNA target following UV irradiation (12, 13) . In the present paper, we describe the results of studies in which we have tested the usefulness of this approach for the purpose of gene inhibition. We have used the interleukin 2 receptor a chain (IL-2Ra) as a test system since recent data from us (11) and others (14) indicate that synthetic oligonucleotides can be used to inhibit IL-2Ra promoter via triple helix formation. Here we show that a psoralen-oligonucleotide conjugate introduces, upon UV irradiation, a doublestrand cross-link in the target promoter in a highly sequencespecific manner. Cross-linking can be induced either in vitro, on isolated plasmid DNA, or within cells after transfection of a reporter plasmid. The cross-linked promoter loses its transcriptional activity both in vitro and in live cells. A mutant of the promoter, in which the oligonucleotide binding site has been inactivated, was not affected by the psoralenoligonucleotide conjugate. These results suggest that such conjugates may be used for selective and possibly irreversible gene inactivation in live cells.
MATERIALS AND METHODS
Plasmids, Oligonucleotides. The wild-type (wt) IL-2Ra chloramphenicol acetyltransferase (CAT) plasmid includes the IL-2Ra sequence from -352 to +110 (kind gift of W. Leonard, National Institutes of Health, Bethesda, MD) subcloned into pGEM-CAT C (a kind gift from 0. Brison; ref. 15 ). The wt IL-2R fos-CAT plasmid was constructed by subcloning the Cla I/Xmn I fragment of IL-2Ra CAT into a fos-CAT construct (16) and includes the IL-2Ra sequence from -349 to -226 and the fos sequence from -99 to +42. Mutations were introduced into both plasmids by PCR (17) and the oligonucleotides, 5'-GGAATCTCCCagaCCTTTAbbreviations: CAT, chloramphenicol acetyltransferase; IL-2Ra, interleukin 2 receptor a chain; wt, wild type; Pso-15-mer, psoralenoligonucleotide conjugate; HTLV-I, human T-lymphotropic virus type I; HIV, human immunodeficiency virus; LTR, long terminal repeat.
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TATGG-3' and complementary strand, with external primers located in the vector. Constructs were verified by direct nucleotide sequencing of the whole insert using a Sequenase kit (United States Biochemical). The psoralen-oligonucleotide conjugate (Pso-15-mer) was synthesized according to Takasugi et al. (12) , with a hexamethylene linker between the C-5 position of the psoralen ring and a 5'-terminal thiophosphate of a 15-mer oligonucleotide of sequence 5'-TTT-TCCTCTCCCTCT-3'. Cytosines were replaced by 5-methylcytosines to enhance triplex stability. The IL-2Ra wt/ mutant triple helix CAT plasmid was constructed by inserting the double-stranded 5'-CAAGCTTCTCCCTCTCCTTT-TATACGT-3' oligonucleotide into the Aat II site (located =0.9 kb from the NF-KB binding site) of the pGEM backbone in the IL-2Ra mutant triple helix CAT vector. DNase I Footprinting. Double-stranded DNA fragments containing the triple helix site were prepared by PCR (17), using a forward primer in the vector (Sp6) and a 32P-endlabeled reverse primer located in the IL-2Ra sequence (11); DNA fragments were incubated with increasing doses of Pso-15-mer at pH 6.4 in a buffer containing 10 mM potassium/dipotassium phosphate, supplemented with 2.5 mM EDTA and 0.5 M NaCl. Chemical sequencing and DNase I footprinting were performed by standard procedures (9).
Photoinduced Cross-Linking Experiments in Vitro. Plasmids were incubated with different doses ofPso-15-mer, irradiated on ice for 5 min using a 365-nm monochromatic lamp (Bioblock, Illkirch, France), digested with the EcoRI endonuclease (see Fig. 1A ), and analyzed on an agarose minigel soaked in 0.03 M NaOH/1 mM EDTA. The gel was then stained with ethidium bromide by standard procedures (18) .
In Vitro Transcription Assay. wt or mutated IL-2R fos-CAT plasmids were incubated with or without Pso-15-mer, irradiated at 365 nm (aliquots were used for control of interstrand cross-link on a denaturing gel, as shown in Fig. 2B ), and used as templates in an in vitro transcription assay. In vitro transcription was performed with nuclear proteins extracted (19) from a human T-lymphotropic virus type I (HTLV-I)-positive cell line (C 8166), with 250 ng of fos-CAT constructs and 10 ng of a human immunodeficiency virus (HIV)-long terminal repeat (LTR)-CAT construct (a kind gift of R. Gaynor, University of California, Los Angeles) as an internal control. Incubation was carried out at 30°C for 30 min in the presence of 0.5 mM NTPs/5 mM MgCl2/60 mM KCl/1 mM dithiothreitol/0.3 mM phenylmethylsulfonyl fluoride/0.3 mM EDTA. RNAs, synthesized from both templates, were reverse transcribed by standard procedures and with a reverse primer in the CAT gene as described (16) .
Transfection Experiments. wt, mutated, or wt/mutated IL-2Ra CAT plasmids were incubated with increasing concentrations of Pso-15-mer and irradiated for 5 min; 107 cells (tumor T-cell line HSB2) were transfected by electroporation with 2 ug of the CAT reporter constructs and 5 ,ug of a tax expression vector, pMAX Neo (20) . Electroporation was carried out as described (11) . In the control, pRSV Neo was cotransfected with IL-2Ra CAT to keep the total transfected DNA constant. CAT assays were performed 24 h later by standard procedures (11) . Transfection efficiency was assayed by direct detection of intracellular plasmid (16) . In addition, an RSV-luc plasmid (a kind gift of H. JacqueminSablon, IGR, Villejuig, France), which includes the firefly luciferase gene under the control of the Rous sarcoma virus LTR, was cotransfected in some experiments, and luciferase activity was monitored by standard procedures (21 Conjugates to the IL-2Ra Promoter. The 5'-thiophosphate of a 15-mer oligonucleotide (Fig. 1B) containing thymines and 5-methylcytosines (to increase the stability ofthe triple helix; refs. 23 and 24) was covalently linked to 5-0-hexylpsoralen as described (12) . This oligonucleotide (Pso-15-mer) binds to a homopyrimidinehomopurine target sequence in the promoter of the IL-2Ra gene (Fig. 1B) , where it forms a triple helix. The target sequence (11) (12) . The crosslinks involve the 3,4 and 4',5' double bond of the psoralen ring (Fig. 1B) (Fig. 3) . Results with the wt promoter showed a direct correlation between the fraction of covalent interstrand cross-link (Fig. 3A, lanes 3-7) and the inhibition of tax response (Fig. 3B, lanes 3-7) , yielding "80% of both crosslinks and subsequent gene repression with an oligonucleotide concentration as low as 0.2 ,M (Fig. 3C) . The inhibition was sequence specific, since the mutated form ofthe promoter was not inhibited (Fig. 3B, lanes 9-11, 16, and 17) .
To demonstrate that inhibition was not due to a special behavior of the cross-linked plasmid, such as rapid degradation or sequestration into a cell compartment, a wild-type triple helix binding site was introduced into the mutant construct 0.9 kb from the NF-KB binding site (construct IL-2Ra wt/mut TH CAT in Fig. 1A ). In the presence of the Pso-15-mer oligonucleotide, cross-linking was observed only in the backbone vector, as expected, and not in the promoter, due to the mutation of the original triple helix site (Fig. 3A,  lane 17) . Expression of the cross-linked plasmid was not affected (Fig. 3B, (Fig. 4) . Cells were then washed, irradiated, and assayed both for intracellular interstrand cross-links (Fig. 4A ) and for CAT activity (Fig. 4 B and C) . A significant fraction of the intracellular wt target promoter was detected as a cross-linked product (Fig. 4A, lane 4) , and cross-linking was accompanied by a similar decrease in CAT activity (Fig. 4B,  lane 3) . In contrast, the mutant promoter, used as a control for sequence-specific effects, was not affected by this treatment (Fig. 4 A and B, lanes 6) . The wt promoter function was 70% inhibited with 20 ,M Pso-15-mer in the culture medium (Fig. 4C ). This concentration is higher than that used when the covalent triplex was preformed in vitro. Several phenom- ena are likely to explain this difference between the in vitro and in vivo results. Irradiation in vitro was carried out at acidic pH (pH 6.4), which is known to increase triple helix stability (4, 5, 9, 12, 24) . In addition, the intracellular concentration of oligonucleotide is not known. A percentage of the oligonucleotides are likely to be trapped by proteins, as observed after microinjection (28) .
One of the main pitfalls of gene inhibition strategies using synthetic oligonucleotides, such as the antisense approach, is the likely transience of any observed effect. Being directed against a gene product and not the gene itself, antisense oligonucleotides will not have permanent effects, unless they induce an irreversible effect in the target cells such as differentiation. This might represent a major problem when antisense oligonucleotides are used for therapeutic purposes. Alternatively, antigene oligonucleotides, when used to direct a chemical agent toward a selected DNA target irt a highly sequence-specific manner, may represent useful tools in overcoming this problem.
In this paper, we have used an oligonucleotide-psoralen conjugate to introduce a double-strand cross-link into the promoter of the IL-2Ra gene. Our data indicate that this damage is introduced in a highly sequence-specific manner and results in the inhibition of reporter gene expression both in vitro and in live cells.
The efficiency of this approach for targeting cellular genes will depend on both the accessibility of the target sequence, as for any triple helix strategy, and the ability of the cells to repair such lesions. Additional studies will allow further insight into this problem.
